157 related articles for article (PubMed ID: 36203437)
1. GLUD1 suppresses renal tumorigenesis and development
Wang L; Fang Z; Gao P; Zheng J
Front Oncol; 2022; 12():975517. PubMed ID: 36203437
[TBL] [Abstract][Full Text] [Related]
2. SDHB Suppresses the Tumorigenesis and Development of ccRCC by Inhibiting Glycolysis.
Fang Z; Sun Q; Yang H; Zheng J
Front Oncol; 2021; 11():639408. PubMed ID: 34094922
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis identifies GLUD1 as a prognostic indicator for clear cell renal cell carcinoma.
Liu S
Eur J Med Res; 2024 Jan; 29(1):70. PubMed ID: 38245763
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma.
Fan D; Liu Q; Wu F; Liu N; Qu H; Yuan Y; Li Y; Gao H; Ge J; Xu Y; Wang H; Liu Q; Zhao Z
PeerJ; 2020; 8():e9261. PubMed ID: 32547875
[TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
6. SPRR3, a novel miR-338-3p target, regulates the malignant progression of clear cell renal cell carcinoma
Wu M; Guo Q; Liu X; Wu L
Exp Ther Med; 2022 May; 23(5):317. PubMed ID: 35350667
[TBL] [Abstract][Full Text] [Related]
7. FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway.
Jiang K; Xu LZ; Ning JZ; Cheng F
Cancer Cell Int; 2023 Sep; 23(1):217. PubMed ID: 37752545
[TBL] [Abstract][Full Text] [Related]
8. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
10. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma.
Li N; Chen J; Liu Q; Qu H; Yang X; Gao P; Wang Y; Gao H; Wang H; Zhao Z
PeerJ; 2021; 9():e11901. PubMed ID: 34458019
[TBL] [Abstract][Full Text] [Related]
12. The role of stearoyl-coenzyme A desaturase 1 in clear cell renal cell carcinoma.
Wang H; Zhang Y; Lu Y; Song J; Huang M; Zhang J; Huang Y
Tumour Biol; 2016 Jan; 37(1):479-89. PubMed ID: 26224474
[TBL] [Abstract][Full Text] [Related]
13. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.
Sui Y; Lu K; Fu L
PeerJ; 2021; 9():e11272. PubMed ID: 33976979
[TBL] [Abstract][Full Text] [Related]
14. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling.
Peng XS; Yang JP; Qiang YY; Sun R; Cao Y; Zheng LS; Peng LX; Lang YH; Mei Y; Li CZ; Meng DF; Liu ZJ; Wang MD; Zhou FJ; Huang BJ; Qian CN
Mol Cancer Res; 2020 Jun; 18(6):903-912. PubMed ID: 32169891
[TBL] [Abstract][Full Text] [Related]
15. OTUD1 stabilizes PTEN to inhibit the PI3K/AKT and TNF-alpha/NF-kappaB signaling pathways and sensitize ccRCC to TKIs.
Liu W; Yan B; Yu H; Ren J; Peng M; Zhu L; Wang Y; Jin X; Yi L
Int J Biol Sci; 2022; 18(4):1401-1414. PubMed ID: 35280681
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
17. METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression.
Liu Z; Sun T; Piao C; Zhang Z; Kong C
J Transl Med; 2021 May; 19(1):209. PubMed ID: 33985542
[TBL] [Abstract][Full Text] [Related]
18. CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma.
Zheng Z; Cai Y; Chen H; Chen Z; Zhu D; Zhong Q; Xie W
Front Oncol; 2018; 8():682. PubMed ID: 30723697
[TBL] [Abstract][Full Text] [Related]
19. Lactotransferrin Downregulation Serves as a Potential Predictor for the Therapeutic Effectiveness of mTOR Inhibitors in the Metastatic Clear Cell Renal Cell Carcinoma without
Zheng JQ; Lin CH; Lee HH; Wang WK; Tong YS; Lee KY; Chiu HW; Lin YF
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944711
[TBL] [Abstract][Full Text] [Related]
20. NDUFA4L2 is associated with clear cell renal cell carcinoma malignancy and is regulated by ELK1.
Wang L; Peng Z; Wang K; Qi Y; Yang Y; Zhang Y; An X; Luo S; Zheng J
PeerJ; 2017; 5():e4065. PubMed ID: 29158991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
